140 related articles for article (PubMed ID: 26323558)
1. MiR-873 acts as a novel sensitizer of glioma cells to cisplatin by targeting Bcl-2.
Chen X; Zhang Y; Shi Y; Lian H; Tu H; Han S; Peng B; Liu W; He X
Int J Oncol; 2015 Oct; 47(4):1603-11. PubMed ID: 26323558
[TBL] [Abstract][Full Text] [Related]
2. MiR-16 modulate temozolomide resistance by regulating BCL-2 in human glioma cells.
Han J; Chen Q
Int J Clin Exp Pathol; 2015; 8(10):12698-707. PubMed ID: 26722459
[TBL] [Abstract][Full Text] [Related]
3. Migration-prone glioma cells show curcumin resistance associated with enhanced expression of miR-21 and invasion/anti-apoptosis-related proteins.
Yeh WL; Lin HY; Huang CY; Huang BR; Lin C; Lu DY; Wei KC
Oncotarget; 2015 Nov; 6(35):37770-81. PubMed ID: 26473373
[TBL] [Abstract][Full Text] [Related]
4. MiR-136 targets E2F1 to reverse cisplatin chemosensitivity in glioma cells.
Chen W; Yang Y; Chen B; Lu P; Zhan L; Yu Q; Cao K; Li Q
J Neurooncol; 2014 Oct; 120(1):43-53. PubMed ID: 25139024
[TBL] [Abstract][Full Text] [Related]
5. MiRNA-451 plays a role as tumor suppressor in human glioma cells.
Nan Y; Han L; Zhang A; Wang G; Jia Z; Yang Y; Yue X; Pu P; Zhong Y; Kang C
Brain Res; 2010 Nov; 1359():14-21. PubMed ID: 20816946
[TBL] [Abstract][Full Text] [Related]
6. miR-503 regulates the resistance of non-small cell lung cancer cells to cisplatin by targeting Bcl-2.
Qiu T; Zhou L; Wang T; Xu J; Wang J; Chen W; Zhou X; Huang Z; Zhu W; Shu Y; Liu P
Int J Mol Med; 2013 Sep; 32(3):593-8. PubMed ID: 23856992
[TBL] [Abstract][Full Text] [Related]
7. MiR-16-1 plays a role in reducing migration and invasion of glioma cells.
Li X; Ling N; Bai Y; Dong W; Hui GZ; Liu D; Zhao J; Hu J
Anat Rec (Hoboken); 2013 Mar; 296(3):427-32. PubMed ID: 23175429
[TBL] [Abstract][Full Text] [Related]
8. REV3L confers chemoresistance to cisplatin in human gliomas: the potential of its RNAi for synergistic therapy.
Wang H; Zhang SY; Wang S; Lu J; Wu W; Weng L; Chen D; Zhang Y; Lu Z; Yang J; Chen Y; Zhang X; Chen X; Xi C; Lu D; Zhao S
Neuro Oncol; 2009 Dec; 11(6):790-802. PubMed ID: 19289490
[TBL] [Abstract][Full Text] [Related]
9. miR‑501‑3p sensitizes glioma cells to cisplatin by targeting MYCN.
Zhang CG; Yang F; Li YH; Sun Y; Liu XJ; Wu X
Mol Med Rep; 2018 Nov; 18(5):4747-4752. PubMed ID: 30221699
[TBL] [Abstract][Full Text] [Related]
10. Is mda-7/IL-24 a potential target and biomarker for enhancing drug sensitivity in human glioma U87 cell line?
Wang Q; Zhu Y; Yang P
Anat Rec (Hoboken); 2013 Aug; 296(8):1154-60. PubMed ID: 23794295
[TBL] [Abstract][Full Text] [Related]
11. TIMP3 regulates osteosarcoma cell migration, invasion, and chemotherapeutic resistances.
Han XG; Li Y; Mo HM; Li K; Lin D; Zhao CQ; Zhao J; Tang TT
Tumour Biol; 2016 Jul; 37(7):8857-67. PubMed ID: 26749283
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin increases B-cell-lymphoma-2 expression via activation of protein kinase C and Akt2 in endometrial cancer cells.
Rouette A; Parent S; Girouard J; Leblanc V; Asselin E
Int J Cancer; 2012 Apr; 130(8):1755-67. PubMed ID: 21618512
[TBL] [Abstract][Full Text] [Related]
13. miR-656 inhibits glioma tumorigenesis through repression of BMPR1A.
Guo M; Jiang Z; Zhang X; Lu D; Ha AD; Sun J; Du W; Wu Z; Hu L; Khadarian K; Shen J; Lin Z
Carcinogenesis; 2014 Aug; 35(8):1698-706. PubMed ID: 24480809
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1.
Tu Y; Gao X; Li G; Fu H; Cui D; Liu H; Jin W; Zhang Y
Cancer Res; 2013 Oct; 73(19):6046-55. PubMed ID: 23950210
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of miR-95-3p inhibits proliferation, and invasion promoting apoptosis of glioma cells by targeting CELF2.
Fan B; Jiao BH; Fan FS; Lu SK; Song J; Guo CY; Yang JK; Yang L
Int J Oncol; 2015 Sep; 47(3):1025-33. PubMed ID: 26165303
[TBL] [Abstract][Full Text] [Related]
16. miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP.
Zhu W; Xu H; Zhu D; Zhi H; Wang T; Wang J; Jiang B; Shu Y; Liu P
Cancer Chemother Pharmacol; 2012 Mar; 69(3):723-31. PubMed ID: 21993663
[TBL] [Abstract][Full Text] [Related]
17. Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells.
Sawada M; Nakashima S; Banno Y; Yamakawa H; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Nozawa Y
Oncogene; 2000 Jul; 19(31):3508-20. PubMed ID: 10918609
[TBL] [Abstract][Full Text] [Related]
18. MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine.
Xiang Y; Ma N; Wang D; Zhang Y; Zhou J; Wu G; Zhao R; Huang H; Wang X; Qiao Y; Li F; Han D; Wang L; Zhang G; Gao X
Oncogene; 2014 Jan; 33(3):378-86. PubMed ID: 23318422
[TBL] [Abstract][Full Text] [Related]
19. miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines.
Zhu W; Shan X; Wang T; Shu Y; Liu P
Int J Cancer; 2010 Dec; 127(11):2520-9. PubMed ID: 20162574
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA‑873 inhibits the progression of thyroid cancer by directly targeting ZEB1.
Jiao D; Guo F; Fu Q
Mol Med Rep; 2019 Aug; 20(2):1986-1993. PubMed ID: 31257462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]